Publikationen

Wissenschaftliche Publikationen mit SCQM Daten

Hier finden Sie verschiedene Publikationen, die auf SCQM Daten basieren.

Jahr Titel Autoren Journal Laienzusammenfassung
2024

Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry

Vallejo-Yagüe, Burkard, Finckh et al. Journal: BMJ Open
2024

Comparative Treatment Effectiveness In Rheumatoid Arthritis With And Without Concomitant Sjögren’s Disease - Results From The Swiss Clinical Quality Management Cohort

Christ, Kissling, Kollert et. al. Journal: Arthritis Research & Therapy
2024

Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis

Mongin, Pagano & Vuilleumier et al. Journal: Frontiers in Cardiovascular Medicine
2024

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network.

Hellamand, van de Sande, van der Horst-Bruinsma et al. Journal: RMD Open
2024

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

Christiansen, Rasmussen, Ørnbjerg et al. Journal: Seminars in Arthritis and Rheumatism
2024

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

Hellamand, van de Sande, van der Horst-Bruinsma et al. Journal: Arthritis & Rheumatology
2024

Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care

Ørnbjerg, Rugbjerg, Østergaard et al. Journal: The Journal of Rheumatology Laienzusammenfassungen: PDF
2024

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

Ørnbjerg, Brahe, Hetland et al. Journal: Joint Bone Spine
2024

Enthesitis in a European registry-based cohort of patients with psoriaticarthritis treated with tumour necrosis factor inhibitors: clinical burden,patient-reported outcomes, and treatment response

Mathew, Lund, Østergaard et al. Journal: Scandinavian Journal of Rheumatology Laienzusammenfassungen: PDF
2024

Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases

Trottet, Allam & Ospelt et al. Journal: PLOS Digital Health Laienzusammenfassungen: PDF
2024

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

Christiansen, Rasmussen, Ørnbjerg et al. Journal: RMD Open
2024

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

Linde, Georgiadis, Østergaard et al. Journal: American College of Rheumatology
2024

Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

Georgiadis, Midtbøll Ørnbjerg, Hetland et al. Journal: The Journal of Rheumatology
2023

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry

Ciurea, Götschi & Micheroli et al. Journal: RMD Open
2023

Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: Longitudinal observational data from the Swiss Clinical Quality Management Registry

Popova, Kissling & Ciurea et al. Journal: Arthritis Research & Therapy
2023

Anaemia is associated with higher disease activity in axial spondyloarthritis, but is not an independent predictor of spinal radiographic progression: Data from the Swiss Clinical Quality Management Registry

Micheroli, Kissling & Ciurea et al. Journal: Clinical Rheumatology
2023

One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

Ørnbjerg, Rugbjerg & Hetland et al. Journal: The Journal of Rheumatology
2023

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

Dominique, Lund Hetland, Simon et al. Journal: Arthritis Research & Therapy
2023

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs

Kalweit, Burden & Burkard et al. Journal: PLOS computational Biology
2023

Impact of sex on spinal radiographic progression in axial spondyloarthritis: a longitudinal Swiss cohort analysis over a period of 10 years

Ensslin, Micheroli & Ciurea et al. Journal: RMD Open
2023

Obesity represents an increasing health issue in axial spondyloarthritis, particularly affecting socially disadvantaged patients

Micheroli, Bhatia & Ciurea et al. Journal: The Journal of Rheumatology Laienzusammenfassungen: Editor's Picks Spotlight (in EN)
2023

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care

Riek, Scherer & Finckh et al. Journal: Scientific Reports Laienzusammenfassungen: PDF
2023

Longitudinal associations between body mass index and changes indisease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab

Theresa Burkard, Enriqueta Vallejo-Yagüe et al. Journal: RMD Open Laienzusammenfassungen: PDF
2023

Impact of SARS-CoV2 infection on anti-Apolipoprotein A-1 IgG response in inflammatory rheumatic diseases.

Lamacchia, Mongin & Vuilleumier et al. Journal: Frontiers in Immunology
2023

Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases

Amend, Gilbert & Strowig et al. Journal: Frontiers in Cellular and Infection Microbiology
2023

Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts

Möller, Scholz & Yawalkar et al. Journal: Rheumatology Laienzusammenfassungen: PDF
2023

Differences and similarities between the latest EULAR/ASAS-EULAR recommendations and national guidelines for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Michelsen, Østergaard & Lund Hetland et al. Journal: The Lancet
2023

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Linde, Ørnbjerg & Østergaard et al. Journal: Rheumatology
2023

“Early” axial spondyloarthritis according to the 2023 ASAS consensus definition: characterization of patients and retention of a first TNF inhibitor in a large observational registry

Ciurea, Götschi & Micheroli et al. Journal: RMD Open
2023

Evaluation and comparison of oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies

Lauper, Mongin & Gabay et al. Journal: Joint Bone Spine
2023

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)

Aymon, Mongin & Lauper et al. Journal: Annals of the Rheumatic Diseases
2023

A potential role for chlamydial infection in rheumatoid arthritis development

Lamacchia, Aymon & Finckh et al. Journal: Rheumatology
2023

Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of reason for withdrawal from the previous treatment

Linde, Ørnbjerg, Brahe et al. Journal: Rheumatology
2023

Commonalities and differences in set-up and data collection across European spondyloarthritis registries

Linde, Ørnbjerg, Rasmussen Journal: Arthritis Research & Therapy
2023

Detection and Grading of Radiographic Hand Osteoarthritis Using an Automated Machine Learning Platform

Caratsch, Lechtenboehmer, Hügle et al. Journal: ACR Open Rheumatology
2022

Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in the Swiss Clinical Quality Management cohort

Vallejo-Yagüe, Burkard & Burden et al. Journal: medRxiv
2022

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort

Ciurea, Kissling & Micheroli et al. Journal: RMD Open
2022

Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12- year data from the SCQM registry

Micheroli, Kissling & Ciurea et al. Journal: RMD Open Laienzusammenfassungen: bechterew.ch
2022

Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort.

Micheroli, Scherer & Tamborrini et al. Journal: Journal of Ultrasonography
2022

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis

Nissen, Delcoigne & Lindström et al. Journal: Rheumatology
2022

Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy

Amstad, Papagiannoulis & Kyburz et al. Journal: Rheumatology
2022

Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort

Vallejo-Yagüe, Burkard & Burden et al. Journal: BMJ Open
2022

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration

Lauper, Iudici & Finckh et al. Journal: Annals of the Rheumatic Diseases
2022

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Ørnbjerg, Linde & Hetland et al. Journal: Seminars in Arthritis and Rheumatism
2022

Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland

Burkard, Vallejo-Yagüe & Burden et al. Journal: BMJ Open Laienzusammenfassungen: PDF
2022

Collaborative challenges of multi-cohort project in pharmacogenetics - why time is essential for meaningful collaborations

Franchini, Kusejko & Leichtle et al. Journal: JMIR Formative Research
2022

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases

Raptis, Berger & Rubbert-Roth et al. Journal: Frontiers in Immunology Laienzusammenfassungen: PDF
2022

Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)

Meissner, Strangfeld & Fischer-Betz Journal: Annals of the Rheumatic Diseases
2022

Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort

Enriqueta Vallejo-Yagüe ,Theresa Burkard et al. Journal: PLOS ONE
2022

Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling

Soomro, Stadler, Barton et. al. Journal: Arthritis & Rheumatology
2022

Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions

Seo, Debray, Ruffieux et al. Journal: Statistical Methods in Medical Research Laienzusammenfassungen: PDF
2021

Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes

Thalmann, Von Kempis & Mueller et al. Journal: Clinical and Experimental Rheumatology
2021

Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factors

Arnold, Jaeger & Kyburz et al. Journal: Rheumatology
2021

Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis

Lechtenboehmer, Burkard & Hügle et al. Journal: Arthritis Research & Therapy
2021

Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis

Lamacchia, Courvoisier & Nissen et al. Journal: Rheumatology
2021

Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction

Shaw, Courvoisier & Finckh et al. Journal: RMD Open
2021

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

Christiansen, Ørnbjerg & Hetland et al. Journal: Rheumatology
2021

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Lindström, Di Giuseppe & Nissen et al. Journal: Annals of the Rheumatic Diseases
2021

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

Nissen, Möller & Hügle et al. Journal: Arthritis Research & Therapy Laienzusammenfassungen: PDF
2021

Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network

Kalweit, Walker & Hügle et al. Journal: PLOS ONE
2021

Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries

Michelsen, Georgiadis & Hetland et al. Journal: Arthritis Care & Research
2021

Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland

Vallejo-Yagüe, Burkard & Burden et al. Journal: Journal of Clinical Medicine Laienzusammenfassungen: PDF
2021

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab

Taleng, Lauper & Finckh et al. Journal: RMD Open
2021

Prediction of sustained biologic and targeted synthetic DMARD free remission in rheumatoid arthritis patients

Burkard, Williams & Burden et al. Journal: Rheumatology Advances in Practice Laienzusammenfassungen: PDF
2020

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Courvoisier, Chatzidionysiou & Finckh et al. Journal: Rheumatology
2020

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland.

Finckh, Tellenbach & Zufferey et al. Journal: RMD Open
2020

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort

Hebeisen, Micheroli & Ciurea et al. Journal: PLOS ONE
2020

Personalized Prediction of Disease Activity in Patients with Rheumatoid Arthritis Using an Adaptive Deep Neural Network

Kalweit, Walker & Hügle et al. Journal: PLOS ONE
2020

Serum calprotectin: A promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Jarlborg, Courvoisier & Nissen et al. Journal: Arthritis Research & Therapy
2020

Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease

Lamacchia, Sollet & Finckh et al. Journal: Rheumatology
2020

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis

Michelsen, Ørnbjerg & Østergaard et al. Journal: Rheumatology
2020

Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort

Micheroli, Tellenbach & Ciurea et al. Journal: Annals of the Rheumatic Diseases
2020

Differences between men and women with nonradiographic axial spondyloarthritis: Clinical characteristics and treatment effectiveness in a real-life prospective cohort

Neuenschwander, Hebeisen & Ciurea et al. Journal: Arthritis Research & Therapy
2020

Tumour Necrosis Factor Inhibitor monotherapy versus combination therapy for the treatment of psoriatic arthritis: combined analysis of European biologics databases

Thomas, Shaddick & Nightingale et al. Journal: The Journal of Rheumatology
2020

Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life

Zufferey, Courvoisier & Finckh et al. Journal: Joint Bone Spine
2020

A Dynamic Deep Neural Network For Multimodal Clinical Data Analysis

Hügle, Kalweit & Boedecker et al. Journal: Springer, Cham
2020

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

Michelsen, Lindström & Østergaard et al. Journal: RMD Open
2020

Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases : results from the Swiss Clinical Quality Management cohort

Ciurea, Papagiannoulis & Finckh et al. Journal: Annals of the Rheumatic Diseases
2019

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts

Boel, Molto & Ramiro et al. Journal: Annals of the Rheumatic Diseases
2019

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment—results from 12 countries in EuroSpA

Brahe, Ørnbjerg & Hetland et al. Journal: Rheumatology
2019

Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: Results from the SCQM cohort

Alpizar-Rodriguez, Förger & Finckh et al. Journal: Rheumatology
2019

Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution

Lauper, Mongin & courvoisier et al. Journal: Rheumatology
2019

European Network of Pregnancy Registers in Rheumatology (EuNeP)- A n overview of procedures and data collection

Meissner, Strangfeld & Fischer-Betz Journal: Arthritis Research & Therapy
2019

Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years

Möller, Aletaha & Zufferey et al. Journal: Rheumatology
2019

Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Ørnbjerg, Brahe & Østergaard et al. Journal: Annals of the Rheumatic Diseases
2019

Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric

Voshaar, Vonkeman & van de Laar et al. Journal: Quality of Life Research
2019

Bone erosion scoring for rheumatoid arthritis with deep convolutional neural networks

Rohrbach, Reinhard & Dürr et al. Journal: Computers & Electrical Engineering
2019

The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis

Scholz, Leichtle & Möller et al. Journal: British Journal of Haematology
2019

Brief report: Influence of Disease Activity in Rheumatoid Arthritis on Radiographic Progression of Concomitant Interphalangeal Joint Osteoarthritis

Lechtenboehmer, Jaeger & Hügle et al. Journal: Arthritis & Rheumatology
2019

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab inpatients with axial spondyloarthritis

Hebeisen, Scherer & Ciurea et al. Journal: PLOS ONE
2018

Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis

Didden, Ruffieux & Egger et al. Journal: Medical Decision Making
2018

Response to tumor necrosis factor inhibition in male and female patients with ankylosing spondylitis: Data from a Swiss Cohort

Hebeisen, Neuenschwander & Ciurea et al. Journal: The Journal of Rheumatology
2018

Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort

Heinimann, Von Kempis & Müller et al. Journal: Journal of Clinical Medicine
2018

Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis

Lauper, Courvoisier & Gabay et al. Journal: Arthritis Care & Research
2018

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Lauper, Nordström & Gabay et al. Journal: Annals of the Rheumatic Diseases
2018

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

Lauper, Mongin & Gabay et al. Journal: RMD Open
2018

Comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance

Martinez-Prat, Nissen & Mahler et al. Journal: Frontiers in Immunology
2018

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: Results from the Swiss Clinical Quality Management cohort

Molnar, Scherer & Ciurea et al. Journal: Annals of the Rheumatic Diseases
2018

Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: Results from the swiss prospective observational cohort

Mueller, Kaegi & von Kempis et al. Journal: RMD Open
2018

Can ultrasound be used to predict loss of remission in patients with RA in a real-life setting? A multicenter cohort study

Zufferey, Scherer & Ziswiler et al. Journal: The Journal of Rheumatology
2017

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life

Chaigne, Finckh & Chizzolini et al. Journal: Quality of Life Research
2017

Rituximab retreatment in rheumatoid arthritis in a real-life cohort: Data from the CERERRA collaboration

Chatzidionysiou, Lie & van Vollenhoven et al. Journal: The Journal of Rheumatology
2017

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)

Iannone, Courvoisier & Finckh et al. Journal: Clinical Rheumatology
2017

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics : results from a collaborative project of 11 European biologic registers

Mercer, Askling & Listing et al. Journal: Annals of the Rheumatic Diseases
2017

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

Micheroili, Hebeisen & Ciurea et al. Journal: Arthritis Research & Therapy
2017

Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)

Mueller, Reshiti & von Kempis et al. Journal: Clinical Rheumatology
2017

Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping

Stekhoven, Scherer & Möller et al. Journal: Clinical Rheumatology
2016

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration

Chatzidionysiou, Lie & van Vollenhoven et al. Journal: Arthritis Research & Therapy
2016

Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis Results from the Swiss Clinical Quality Management Cohort

Ciurea, Exer & Scherer et al. Journal: Arthritis Research & Therapy
2016

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

Ciurea, Scherer & Finckh et al. Journal: Annals of the Rheumatic Diseases
2016

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

Courvoisier, Alpizar-Rodriguez & Finckh et al. Journal: eBioMedicine
2016

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Results from a European collaborative study

Gabay, Riek & Kvien et al. Journal: Annals of the Rheumatic Diseases
2016

Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity with Better Effectiveness of Abatacept: Results from the Pan-European Registry Analysis

Gottenberg, Courvoisier & Finckh et al. Journal: Arthritis & Rheumatology
2016

The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis

Nissen, Ciurea & Finckh et al. Journal: Arthritis & Rheumatology
2015

Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: Comparison between private rheumatology practices and academic centers in a large observational cohort

Ciurea, Weber & Exer et al. Journal: The Journal of Rheumatology
2015

Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: Data from the Swiss Clinical Quality Management Registry

Gabay, Riek & Finckh et al. Journal: Rheumatology
2015

Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study

Möller, Pruijm & Finckh et al. Journal: Annals of the Rheumatic Diseases
2015

The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis

Mueller, Schiff & von Kempis et al. Journal: Clinical Rheumatology
2015

Rituximab done: What's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

Walker, Jaeger & Gabay et al. Journal: Rheumatology
2015

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Finckh, Neto & Turesson et al. Journal: RMD Open
2014

Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs?

Ciubotariu, Gabay & Finckh Journal: The Journal of Rheumatology
2014

Age at symptom onset in ankylosing spondylitis: Is there a gender difference?

Ciurea, Scherer & Stekhoven et al. Journal: Annals of the Rheumatic Diseases
2014

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: A prospective cohort study

Möller, Scherer & Finckh et al. Journal: Annals of the Rheumatic Diseases
2014

Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis

Mueller, Kaegi & von Kempis et al. Journal: Rheumatology
2014

Ultrasound evaluation of synovitis in RA: Correlation with clinical disease activity and sensitivity to change in an observational cohort study

Zufferey, Brulhart & Ziswiler et al. Journal: Joint Bone Spine
2014

Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: Results of an observational cohort study

Zufferey, Möller & Ziswiler et al. Journal: Joint Bone Spine
2013

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: Results from a large observational cohort

Ciurea, Scherer & Weber et al. Journal: Arthritis & Rheumatism
2013

Smoking and spondyloarthritis

Ciurea & Finckh Journal: Joint Bone Spine
2013

Recommendations for the use of ultrasound in rheumatoid arthritis: Literature review and SONAR score experience

Zufferey, Tamborrini & Ziswiler et al. Journal: Swiss Medical Weekly
2013

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: Results from the Swiss SCQM registry

Zufferey, Dudler & Finckh et al. Journal: Joint Bone Spine
2012

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration

Chatzidionysiou, Lie & Gabay et al. Journal: Annals of the Rheumatic Diseases
2012

Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis

Courvoisier, Agoritsas & Finckh et al. Journal: Arthritis Care & Research
2012

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

Martin Du Pan, Scherer & Finckh et al. Journal: Annals of the Rheumatic Diseases
2012

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

Finckh, Möller & Gabay et al. Journal: Annals of the Rheumatic Diseases
2011

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries

Chatzidionysiou, Lie & Vollenhoven et al. Journal: Annals of the Rheumatic Diseases
2011

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.

Kyburz, Gabay & Finckh et al. Journal: Rheumatology
2011

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion

Walker, Courvoisier & Scherer et al. Journal: Rheumatology
2010

A Comparison of Patient Characteristics and Outcomes in Selected European and U.S. Rheumatoid Arthritis Registries

Curtis, Jain & Zink et al. Journal: Seminars in Arthritis and Rheumatism
2010

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Finckh, Ciurea & Gabay et al. Journal: Annals of the Rheumatic Diseases
2010

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients

Finckh, Dudler & Bas et al. Journal: Joint Bone Spine
2010

The effect of alcohol on radiographic progression in rheumatoid arthritis

Nissen, Gabay & Finckh et al. Journal: Arthritis & Rheumatism
2009

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: A population-based study

Finckh, Dehler & Gabay et al. Journal: Annals of the Rheumatic Diseases
2009

Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis

Martin Du Pan, Dehler & Finckh et al. Journal: Arthritis Care & Research
2007

Cigarette smoking and radiographic progression in rheumatoid arthritis

Finckh, Dehler & Gabay et al. Journal: Annals of the Rheumatic Diseases
2007

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents

Finckh, Ciurea & Gabay et al. Journal: Arthritis & Rheumatism
2007

Tolerance and effectiveness of anti-tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study

Genevay, Finckh & Gabay et al. Journal: Arthritis Care & Research
2006

Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

Finckh, Simard & Guerne et al. Journal: Annals of the Rheumatic Diseases
2006

The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population-based study

Finckh, Simard & Guerne et al. Journal: Arthritis & Rheumatism
2006

Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community

Genta, Kardes & Gabay Journal: Joint Bone Spine
2000

Clinical quality management in rheumatoid arthritis: Putting theory into practice

Uitz, Fransen & Stucki et al. Journal: Rheumatology